Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Grill

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Ebiomedicine|October 4, 2024
Alzheimer's disease biomarkers and the tyranny of treatmentJason Karlawish, Joshua D Grill
Neurology|June 5, 2021
Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical TrialsJoshua D Grill, Jason Karlawish
Journal of Neurophysiology|April 4, 2002
Transient analgesia evoked by noxious stimulus offsetJoshua D Grill, Robert C Coghill
Alzheimer'S Research & Therapy|May 26, 2011
Should persons with autosomal dominant AD be included in clinical trials?Joshua D Grill, John M Ringman
Brain Research|May 22, 2002
Age-related and laminar-specific dendritic changes in the medial frontal cortex of the ratJoshua D Grill, David R Riddle
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|September 13, 2007
Recognizing involuntary emotional expression disorderGale Robinson-Smith, Joshua D Grill
The Journal of Prevention of Alzheimer'S Disease|June 13, 2026
Eligibility of men vs. women in Alzheimer's trials: Inclusive vs. representativeJoshua D Grill, Daniel L Gillen
JAMA Neurology|July 15, 2024
Centers for Medicare and Medicaid Services Coverage of Amyloid PETJoshua D Grill, Jennifer H Lingler
Expert Review of Neurotherapeutics|April 28, 2010
Current therapeutic targets for the treatment of Alzheimer's diseaseJoshua D Grill, Jeffrey L Cummings
Neurobiology of Aging|October 15, 2013
Choosing Alzheimer's disease prevention clinical trial populationsJoshua D Grill, Sarah E Monsell
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Ebiomedicine|October 4, 2024
Alzheimer's disease biomarkers and the tyranny of treatmentJason Karlawish, Joshua D Grill
Neurology|June 5, 2021
Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical TrialsJoshua D Grill, Jason Karlawish
Journal of Neurophysiology|April 4, 2002
Transient analgesia evoked by noxious stimulus offsetJoshua D Grill, Robert C Coghill
Alzheimer'S Research & Therapy|May 26, 2011
Should persons with autosomal dominant AD be included in clinical trials?Joshua D Grill, John M Ringman
Brain Research|May 22, 2002
Age-related and laminar-specific dendritic changes in the medial frontal cortex of the ratJoshua D Grill, David R Riddle
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|September 13, 2007
Recognizing involuntary emotional expression disorderGale Robinson-Smith, Joshua D Grill
The Journal of Prevention of Alzheimer'S Disease|June 13, 2026
Eligibility of men vs. women in Alzheimer's trials: Inclusive vs. representativeJoshua D Grill, Daniel L Gillen
JAMA Neurology|July 15, 2024
Centers for Medicare and Medicaid Services Coverage of Amyloid PETJoshua D Grill, Jennifer H Lingler
Expert Review of Neurotherapeutics|April 28, 2010
Current therapeutic targets for the treatment of Alzheimer's diseaseJoshua D Grill, Jeffrey L Cummings
Neurobiology of Aging|October 15, 2013
Choosing Alzheimer's disease prevention clinical trial populationsJoshua D Grill, Sarah E Monsell
Pageof 17